Discovery of BE2012, a First-in-Class REV-ERBα/β Antagonist with Favorable Selectivity and Pharmacokinetics, and In Vivo Efficacy in Inducing Key Myogenic Factors for Muscle Repair upon Acute Muscle Injury. - Maram L; Valfort AC; Homaidur Rahman M; Okda HE; Elagawany M; Politte H; Appourchaux K; Bedia-Diaz G; Côté I; Hegazy L; Burris TP; Elgendy B (Journal of medicinal chemistry, 2026)